Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 4

Sponsor Class

INDUSTRY 3NIH 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Thoracic 14Other solid neoplasm 14Gynecologic 4Gastrointestinal 4Genitourinary 1Breast 1

Conditions

Colorectal Neoplasms 315Pancreatic Neoplasms 186Carcinoma, Hepatocellular 116Stomach Neoplasms 110Colonic Neoplasms 84Esophageal Neoplasms 80Carcinoma, Non-Small-Cell Lung 80Breast Neoplasms 78Rectal Neoplasms 75Ovarian Neoplasms 62Neoplasm Metastasis 59Lung Neoplasms 58Neoplasms 54Cholangiocarcinoma 53Melanoma 45Liver Neoplasms 45Gastrointestinal Neoplasms 43Prostatic Neoplasms 42Biliary Tract Neoplasms 37Endometrial Neoplasms 33Squamous Cell Carcinoma of Head and Neck 31Sarcoma 29Carcinoma, Renal Cell 29Esophageal Squamous Cell Carcinoma 27Uterine Cervical Neoplasms 26Adenocarcinoma Of Esophagus 24Head and Neck Neoplasms 23Urinary Bladder Neoplasms 22Small Cell Lung Carcinoma 20Gastrointestinal Stromal Tumors 17

Interventions

Blood Component Removal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Mesothelioma, Malignant × Gastrointestinal × 30 days × Clear all
NCT06756035 2026-06-04

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Context Therapeutics Inc.

Phase 1 Recruiting
70 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT00242723 2026-06-03

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

National Institutes of Health Clinical Center (CC)

Recruiting
1,559 enrolled
GastrointestinalOther solid neoplasmThoracic

Mesothelioma, Malignant, Esophageal Neoplasms, Lung Neoplasms

NCT04981119 2026-06-02

BASECAMP-1

A2 Biotherapeutics Inc.

Recruiting
200 enrolled
BreastGastrointestinalGenitourinaryGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT06051695 2026-05-26

EVEREST-2

A2 Biotherapeutics Inc.

Phase 1/2 Recruiting
474 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡